ArticleOncotarget2016

TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun.

Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.